Evidence map›Paper›PMID 33681383›Full record

Trial reportBioMed research international2021

Gut Microbiota Profile in Adult Patients with Idiopathic Nephrotic Syndrome.

Hanchang He, Minwa Lin, Lu You, Tongqing Chen, Zijie Liang, Dao Li, Chao Xie, Guanqing Xiao, Peiyi Ye, Yaozhong Kong and 1 more

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Gut Microbiome as a Risk Factor for Future CKD.Kidney international reports · 2025
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Effects ofFrontiers in pharmacology · 2024
    Article
  13. Article
  14. An altered gut microbiome in pre-eclampsia: cause or consequence.Frontiers in cellular and infection microbiology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Hanchang HeDepartment of Nephrology, The First People's Hospital of Foshan, Guangdong Province, Foshan 528000, China.ORCID https://orcid.org/0000-0002-8779-9542
Minwa LinDepartment of Nephrology, The First People's Hospital of Foshan, Guangdong Province, Foshan 528000, China.ORCID https://orcid.org/0000-0002-6307-8548
Lu YouDepartment of Nephrology, The First People's Hospital of Foshan, Guangdong Province, Foshan 528000, China.ORCID https://orcid.org/0000-0002-0474-0415
Tongqing ChenDepartment of Nephrology, The First People's Hospital of Foshan, Guangdong Province, Foshan 528000, China.ORCID https://orcid.org/0000-0002-7790-6543
Zijie LiangDepartment of Nephrology, The First People's Hospital of Foshan, Guangdong Province, Foshan 528000, China.ORCID https://orcid.org/0000-0001-5115-223X
Dao LiDepartment of Nephrology, The First People's Hospital of Foshan, Guangdong Province, Foshan 528000, China.ORCID https://orcid.org/0000-0002-9027-4827
Chao XieDepartment of Nephrology, The First People's Hospital of Foshan, Guangdong Province, Foshan 528000, China.ORCID https://orcid.org/0000-0001-9489-5519
Guanqing XiaoDepartment of Nephrology, The First People's Hospital of Foshan, Guangdong Province, Foshan 528000, China.ORCID https://orcid.org/0000-0002-9457-8238
Peiyi YeDepartment of Nephrology, The First People's Hospital of Foshan, Guangdong Province, Foshan 528000, China.ORCID https://orcid.org/0000-0002-4921-0610
Yaozhong KongDepartment of Nephrology, The First People's Hospital of Foshan, Guangdong Province, Foshan 528000, China.ORCID https://orcid.org/0000-0002-9178-6023
Youlian ZhouDepartment of Gastroenterology, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.ORCID https://orcid.org/0000-0002-7107-3288
First People's Hospital of Foshan · CNBeth Israel Deaconess Medical Center · USGuangzhou First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIncreasing evidences have reported gut microbiota dysbiosis in many diseases, including chronic kidney disease and pediatric idiopathic nephrotic syndrome (INS). There is lack evidence of intestinal microbiota dysbiosis in adults with INS, however. Here, we to address the association between the gut microbiome and INS.

methodsStool samples of 35 adult INS patients and 35 healthy volunteers were collected. Total bacterial DNA was extracted, and the V4 regions of the bacterial 16S ribosomal RNA gene were sequenced. The fecal microbiome was analyzed using bioinformatics. The correlation analysis between altered taxa and clinical parameters was also included.

resultsWe found that microbial diversity in the gut was reduced in adult patients with INS.

conclusionOur findings show compositional alterations of intestinal microbiota in adult patients with INS and correlations between significantly altered taxa and clinical parameters, which points out the direction for the development of new diagnostics and therapeutic approaches targeted intestinal microbiota.

Indexed as

BacteriaGastrointestinal MicrobiomeAdultDNA, BacterialFecesFemaleHumansMaleMiddle AgedNephrotic SyndromeDNA, Bacterial

Identifiers

PMID33681383
PMCPMC7910048
OpenAlexW3129607964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.